Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Common shares
OP units and subordinated performance units
Preferred Shares
Common Shares
Common Shares
Common shares
Additional Paid-in Capital
Additional Paid-in Capital
Common shares
Distributions In Excess Of Earnings
Accumulated Other Comprehensive (Loss) Income
Noncontrolling Interests
Noncontrolling Interests
OP units and subordinated performance units
Beginning balances (in shares) at Dec. 31, 2019       8,727,119                
Beginning balances (in shares) at Dec. 31, 2019         59,659,108              
Beginning balances at Dec. 31, 2019 $ 1,452,101     $ 218,178 $ 597   $ 905,763   $ (197,075) $ (7,833) $ 532,471  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
OP units and subordinated performance units, net of offering costs     $ 6,206                 $ 6,206
LTIP units 1,011                   1,011  
Redemptions of OP units (in shares)         118,961              
Redemptions of OP units 0       $ 1   1,437     (62) (1,376)  
Issuance of shares, net of offering costs (in shares)           125,000            
Issuance of shares, net of offering costs   $ 4,249       $ 1   $ 4,248        
Merger and internalization of PRO, net of issuance costs (in shares)         8,105,192              
Merger and internalization of PRO, net of issuance costs 9,595       $ 81   43,499     (402) (33,583)  
Redemption of Series A-1 preferred units (in shares)       5,600                
Redemption of Series A-1 preferred units 0     $ 140             (140)  
Effect of changes in ownership for consolidated entities 0           15,857     (2,265) (13,592)  
Equity-based compensation expense 774           76       698  
Issuance of LTIP units for acquisition expenses 40                   40  
Issuance of restricted common shares (in shares)         21,861              
Issuance of restricted common shares 0                      
Vesting and forfeitures of restricted common shares, net (in shares)         (2,910)              
Vesting and forfeitures of restricted common shares, net (94)           (94)          
Preferred share dividends (3,273)               (3,273)      
Common share dividends (19,747)               (19,747)      
Distributions to noncontrolling interests (19,813)                   (19,813)  
Other comprehensive income (loss) (65,757)                 (42,293) (23,464)  
Net income 15,763               6,648   9,115  
Ending balances (in shares) at Mar. 31, 2020       8,732,719                
Ending balances (in shares) at Mar. 31, 2020         68,027,212              
Ending balances at Mar. 31, 2020 1,381,055     $ 218,318 $ 680   970,786   (213,447) (52,855) 457,573  
Beginning balances (in shares) at Dec. 31, 2019       8,727,119                
Beginning balances (in shares) at Dec. 31, 2019         59,659,108              
Beginning balances at Dec. 31, 2019 1,452,101     $ 218,178 $ 597   905,763   (197,075) (7,833) 532,471  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Other comprehensive income (loss) (72,246)                      
Net income 33,550                      
Ending balances (in shares) at Jun. 30, 2020       8,732,719                
Ending balances (in shares) at Jun. 30, 2020         68,703,733              
Ending balances at Jun. 30, 2020 1,368,745     $ 218,318 $ 687   984,950   (228,924) (57,462) 451,176  
Beginning balances (in shares) at Mar. 31, 2020       8,732,719                
Beginning balances (in shares) at Mar. 31, 2020         68,027,212              
Beginning balances at Mar. 31, 2020 1,381,055     $ 218,318 $ 680   970,786   (213,447) (52,855) 457,573  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
OP units and subordinated performance units, net of offering costs     5,842                 5,842
Redemptions of OP units (in shares)         292,291              
Redemptions of OP units 0       $ 3   3,438     (238) (3,203)  
Issuance of shares, net of offering costs (in shares)           387,000            
Issuance of shares, net of offering costs   11,916       $ 4   11,912        
Effect of changes in ownership for consolidated entities 0           (1,286)     (73) 1,359  
Equity-based compensation expense 1,151           100       1,051  
Vesting and forfeitures of restricted common shares, net (in shares)         (2,770)              
Vesting and forfeitures of restricted common shares, net 0           0          
Reduction in receivables from partners of the operating partnership 225                   225  
Preferred share dividends (3,274)               (3,274)      
Common share dividends (22,625)               (22,625)      
Distributions to noncontrolling interests (16,843)                   (16,843)  
Other comprehensive income (loss) (6,489)                 (4,296) (2,193)  
Net income 17,787               10,422   7,365  
Ending balances (in shares) at Jun. 30, 2020       8,732,719                
Ending balances (in shares) at Jun. 30, 2020         68,703,733              
Ending balances at Jun. 30, 2020 $ 1,368,745     $ 218,318 $ 687   984,950   (228,924) (57,462) 451,176  
Beginning balances (in shares) at Dec. 31, 2020 8,732,719     8,732,719                
Beginning balances (in shares) at Dec. 31, 2020 71,293,117       71,293,117              
Beginning balances at Dec. 31, 2020 $ 1,430,475     $ 218,318 $ 713   1,050,714   (251,704) (49,084) 461,518  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
OP units and subordinated performance units, net of offering costs     22,897                 22,897
Redemptions of OP units (in shares)         190,248              
Redemptions of OP units 0       $ 2   2,332     (108) (2,226)  
Issuance of shares, net of offering costs (in shares)           3,692,216            
Issuance of shares, net of offering costs   122,412       $ 37   122,375        
Contributions from noncontrolling interests 103                   103  
Effect of changes in ownership for consolidated entities 0           (18,983)     (290) 19,273  
Equity-based compensation expense 1,286           92       1,194  
Issuance of restricted common shares (in shares)         15,369              
Issuance of restricted common shares 0                      
Vesting and forfeitures of restricted common shares, net (in shares)         (4,823)              
Vesting and forfeitures of restricted common shares, net (152)           (152)          
Preferred share dividends (3,275)               (3,275)      
Common share dividends (25,014)               (25,014)      
Distributions to noncontrolling interests (20,604)                   (20,604)  
Other comprehensive income (loss) 25,857                 17,840 8,017  
Net income 27,635               20,838   6,797  
Ending balances (in shares) at Mar. 31, 2021       8,732,719                
Ending balances (in shares) at Mar. 31, 2021         75,186,127              
Ending balances at Mar. 31, 2021 $ 1,581,620     $ 218,318 $ 752   1,156,378   (259,155) (31,642) 496,969  
Beginning balances (in shares) at Dec. 31, 2020 8,732,719     8,732,719                
Beginning balances (in shares) at Dec. 31, 2020 71,293,117       71,293,117              
Beginning balances at Dec. 31, 2020 $ 1,430,475     $ 218,318 $ 713   1,050,714   (251,704) (49,084) 461,518  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Other comprehensive income (loss) 24,256                      
Net income $ 63,310                      
Ending balances (in shares) at Jun. 30, 2021 8,736,719     8,736,719                
Ending balances (in shares) at Jun. 30, 2021 77,708,831       77,708,831              
Ending balances at Jun. 30, 2021 $ 1,687,526     $ 218,418 $ 777   1,244,269   (263,117) (33,046) 520,225  
Beginning balances (in shares) at Mar. 31, 2021       8,732,719                
Beginning balances (in shares) at Mar. 31, 2021         75,186,127              
Beginning balances at Mar. 31, 2021 1,581,620     $ 218,318 $ 752   1,156,378   (259,155) (31,642) 496,969  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
OP units and subordinated performance units, net of offering costs     $ 24,102                 $ 24,102
Redemptions of OP units (in shares)         121,923              
Redemptions of OP units 0       $ 1   1,554     (52) (1,503)  
Issuance of shares, net of offering costs (in shares)           2,390,000            
Issuance of shares, net of offering costs   $ 103,670       $ 24   $ 103,646        
Redemption of Series A-1 preferred units (in shares)       4,000                
Redemption of Series A-1 preferred units 0     $ 100             (100)  
Effect of changes in ownership for consolidated entities 0           (17,420)     (227) 17,647  
Equity-based compensation expense 1,348           113       1,235  
Issuance of restricted common shares (in shares)         13,255              
Issuance of restricted common shares 0                      
Vesting and forfeitures of restricted common shares, net (in shares)         (2,474)              
Vesting and forfeitures of restricted common shares, net (2)           (2)          
Preferred share dividends (3,276)               (3,276)      
Common share dividends (29,404)               (29,404)      
Distributions to noncontrolling interests (24,606)                   (24,606)  
Other comprehensive income (loss) (1,601)                 (1,125) (476)  
Net income $ 35,675               28,718   6,957  
Ending balances (in shares) at Jun. 30, 2021 8,736,719     8,736,719                
Ending balances (in shares) at Jun. 30, 2021 77,708,831       77,708,831              
Ending balances at Jun. 30, 2021 $ 1,687,526     $ 218,418 $ 777   $ 1,244,269   $ (263,117) $ (33,046) $ 520,225